Loniten

HCCC investigates hair regrowth company director

THE director of a hair regrowth company has been banned from selling prescription and pharmacy-only medication to his clients following an investigation by the NSW Health Care Complaints Commission (HCCC). The investigation found that Samuel Cohen, director of the Institute of Hair Regrowth and Beauty, had supplied clients with medication obtained from other clients’ prescriptions. The investigation was launched following a complaint to the HCCC from one of Mr Cohen’s clients that he had paid $3,700 for a hair regrowth treatment program that resulted in an allergic reaction. ...